QLM is pleased to announce its participation with Sidra Medicine in the annual Flagship Research Conference titled ‘Precision Medicine & Functional Genomics 2022’ (PMFG 2022), took place in September 23-26 in Doha, Qatar.
The conference was a four-day in-person, on-site event and revolved around two major themes: i) How cellular, organoid, and animal models are being used to facilitate the discovery of basic disease mechanisms and potential cures and ii) The development of advanced therapies to treat diseases. The conference assembled a unique and highly interdisciplinary international community to provide novel insights on the molecular mechanisms underlying genetic diseases and the strategies used to develop advanced therapies.
As a diamond sponsor, QLM had its own booth present, showcasing its diverse medical and life products and its robust healthcare services.
Ahmed Mohammed Zebeib, QLM Deputy Chief Executive Officer, said: “This conference serves as an important Corporate Social Responsibility (CSR) initiative, and an opportunity to engage with the wider community. QLM remains committed in advocating for science and education within the medical practice.”
QLM Life & Medical Insurance Company is a public listed company specialized in life and medical insurance solutions and is regulated by the Qatar Central Bank. QLM provides best-in-class service to its clients, with a unique value proposition. The Company’s vision is to continuously provide outstanding medical and life coverage, by becoming a trusted healthcare partner.
